SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-014308
Filing Date
2021-06-14
Accepted
2021-06-14 16:01:52
Documents
72
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 498614
2 ex31-1.htm EX-31.1 20196
3 ex31-2.htm EX-31.2 19453
4 ex32-1.htm EX-32.1 7459
5 ex32-2.htm EX-32.2 7206
  Complete submission text file 0001493152-21-014308.txt   3780598

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE adxs-20210430.xml EX-101.INS 697852
7 XBRL SCHEMA FILE adxs-20210430.xsd EX-101.SCH 46193
8 XBRL CALCULATION FILE adxs-20210430_cal.xml EX-101.CAL 64190
9 XBRL DEFINITION FILE adxs-20210430_def.xml EX-101.DEF 170706
10 XBRL LABEL FILE adxs-20210430_lab.xml EX-101.LAB 323549
11 XBRL PRESENTATION FILE adxs-20210430_pre.xml EX-101.PRE 274078
Mailing Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852
Business Address 9 DEER PARK DRIVE SUITE K-1 MONMOUTH JUNCTION NJ 08852 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 001-36138 | Film No.: 211014578
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences